Clinical Microbiology and Antimicrobial Chemotherapy. 2021; 23(3):314-329
Objective. To review and summarize literature data in studies of safety of the drug products used for the pathogenetic treatment of COVID-19.
Materials and Methods. As the first stage of monitoring the drug’s safety, which are used in the treatment of COVID-19 in Russia, a systematic review of studies of the drug’s safety profiles was carried out: mefloquine, hydroxychloroquine, azithromycin, lopinavir/ritonavir, favipiravir, tocilizumab, olokizumab, baricitinib in the international databases Medline, PubMed, ClinicalTrials.